New Relic, Inc. (NEWR)

About New Relic, Inc.

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

Headquarters: Bresso, MI · Employees: 27 · Website: https://www.newron.com

Product categories

• Cloud Computing

Competitors of New Relic, Inc.

• Alphabet Inc. (GOOGL)
• Apple Inc. (AAPL)
• MICROSOFT CORP (MSFT)
• AMAZON COM INC (AMZN)
• Meta Platforms, Inc. (META)
• Samsung Electronics Co., Ltd. (005930.KS)
• Tencent Holdings Limited (0700.HK)
• INTEL CORP (INTC)
• ORACLE CORP (ORCL)
• CISCO SYSTEMS, INC. (CSCO)
• NETFLIX INC (NFLX)
• Palantir Technologies Inc. (PLTR)

Frequently asked questions about New Relic, Inc. (NEWR)

What is New Relic, Inc. (NEWR)?

New Relic, Inc. (NEWR) is a publicly traded company in the Healthcare sector (Biotechnology). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are New Relic, Inc.'s main competitors?

Competitors of New Relic, Inc. (NEWR) tracked by Macroplane include Alphabet Inc. (GOOGL), Apple Inc. (AAPL), MICROSOFT CORP (MSFT), AMAZON COM INC (AMZN), Meta Platforms, Inc. (META), Samsung Electronics Co., Ltd. (005930.KS), Tencent Holdings Limited (0700.HK), INTEL CORP (INTC), and 4 more.